Ireland· IE-PA-EU/1/07/423/001-003
Vectibix 20 mg/mL concentrate for solution for infusion
A panitumumab product containing panitumumab, registered in Ireland by Amgen Europe B.V.,. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Panitumumab is registered in 2 of 19 countries.
Countries holding a registration under ATC L01XC08 (panitumumab), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Panitumumab · ATC L01XC08
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Panitumumab
- Manufacturer
- Amgen Europe B.V.,
- Country
- Ireland (IE)
- ATC code
- L01XC08
- ATC class
- Panitumumab
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/07/423/001-003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
27 interactions on record for panitumumab.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Panitumumab · interactions on record
27 records
- 14 severe
- 13 moderate
Most severe, free to view
- AmiodaroneC01BD01severe
- DofetilideC01BD04severe
- DronedaroneC01BD07severe
- IrinotecanL01CE02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Panitumumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVectibix 20 mg/mlAmgen Europe
- CzechiaVECTIBIXAmgen Europe B.V., Breda
- FinlandVectibixAmgen Europe B.V.
- IcelandVectibixAmgen Europe B.V.*
- NorwayVectibixAmgen Europe B.V.
- PolandVectibixAmgen Europe B.V.
- SwedenVectibix 20 mg/ml Koncentrat till infusionsvätska, lösningAmgen Europe B.V.
- United StatesVectibixAmgen, Inc
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Vectibix
- Norway · Vectibix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2471ee6-12b6-48b3-ad06-4637cddf3e03 GET /v1/drugs/e2471ee6-12b6-48b3-ad06-4637cddf3e03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L01XC",
"L01XC08"
],
"strength": null,
"pa_number": "EU/1/07/423/001-003",
"substances": [
"Panitumumab"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about panitumumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.